振德医疗：控股股东及其一致行动人协议转让约1332万股

Group 1 - The core point of the article is that Zhende Medical announced a share transfer agreement involving approximately 13.32 million shares, representing 5% of the company's total share capital, at a price of RMB 26.74 per share, totaling around RMB 356 million [1] - The share transfer will not trigger a mandatory bid and will not change the controlling shareholder or actual controller of the company [1] - The transfer is aimed at reducing the shareholding of the current shareholders for their own development and funding arrangements while introducing investors who are optimistic about the company's future [1] Group 2 - For the first half of 2025, Zhende Medical's revenue composition is entirely from medical dressings, accounting for 100% [2] - As of the report date, Zhende Medical has a market capitalization of RMB 7.8 billion [3]